LMP1-Induced Downregulation of CD99 Molecules in Hodgkin and Reed-Sternberg Cells

References

• Hodgkin T. On some morbid experiences of the absorbent glands and spleen. Med Chir Trans 1832; 17: 68–97
   PubMedGoogle Scholar
• Wilks S. Cases of enlargement of the lymphatic glands and spleen or Hodgkin's disease. Guys Hosp Res 1865; 11: 56–67
   Google Scholar
• Reed D. On the pathological changes in Hodgkin's disease, with special reference to its relationship to tuberculosis. J Hopkins Hosp Rep 1902; 10: 133–196
   Google Scholar
• Sternberg C. Über eine eigenartige unter dem Bilde der Pseudoleukämie verlaufende Tuberkulose des lymphatischen Apparates. Z Heilkunde 1898; 19: 21–90
   Google Scholar
• Baumforth K. R., Young L. S., Flavell K. J., Constandinou C., Murray P. G. The Epstein-Barr virus and its association with human cancers. Mol Pathol 1999; 52: 307–322
   PubMedGoogle Scholar
• Li D., Oda K., Mikata A., Yumoto N. Epstein-Barr virus genomes in Hodgkin's disease and non-Hodgkin's lymphomas. Pathol Int 1995; 45: 735–741
   PubMed Web of Science ®Google Scholar
• Pallesen G., Hamilton-Dutoit S. J., Rowe M., Young L. S. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991; 337: 320–322
   PubMed Web of Science ®Google Scholar
• Kim S. H., Choi E. Y., Shin Y. K., Kim T. J., Chung D. H., Chang S. I., Kim N. K., Park S. H. Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 Mic2. Blood 1998; 92: 4287–4295
   PubMed Web of Science ®Google Scholar
• Kim S. H., Shin Y. K., Lee I-S, Bae Y. M., Sohn H. W., Suh Y. H., Ree H. J., Rowe M., Park S. H. Viral latent membrane protein 1 (LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype. Blood 2000; 95: 294–300
   PubMed Web of Science ®Google Scholar
• Sohn H. W., Shin Y. K., Lee I-S., Bae Y. M., Suh Y. H., Kim M. K., Kim T. J., Jung K. C., Park W. S., Park C. S., Chung D. H., Ahn K., Kim I. S., Ko Y. H., Bang Y. J., Kim C. W., Park S. H. CD99 regulates the transport of MHC class I molecules from the Golgi complex to the cell surface. J. Immunol. 2001; 166: 787–794
   PubMed Web of Science ®Google Scholar
• Drexler H. G. Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material. Leuk Lymphoma 1992; 8: 283–313
   PubMed Web of Science ®Google Scholar
• Kadin M. E. Pathology of Hodgkin's disease. Curr Opin Oncol 1994; 6: 456–463
   PubMedGoogle Scholar
• Haluska F. G., Brufsky A. M., Canellos G. P. The cellular biology of the Reed-Sternberg cell. Blood 1994; 84: 1005–1019
   PubMed Web of Science ®Google Scholar
• Rajewsky K., Küppers R. The origin of Hodgkin and reed/sternberg cells in Hodgkin's disease. Annu Rev Immunol 1998; 16: 471–493
   PubMed Web of Science ®Google Scholar
• Cossman J., Messineo C., Bagg A. Reed-sternberg cell: Survival in a hostile sea. Lab Invest 1998; 78: 2229–2235
   Web of Science ®Google Scholar
• Drexler H. G., Minowada J. Hodgkin's disease derived cell lines: a review. Hum Cell 1992; 5: 42–53
   PubMedGoogle Scholar
• Gelin C., Aubrit F., Phalipon A., Raynal B., Cole S., Kaczorek M., Bernard A. The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product. EMBO J 1989; 8: 3253–3259
   PubMed Web of Science ®Google Scholar
• Rosenkranz A. R., Majdic O., Stockl J., Pickl W., Stockinger H., Knapp W. Induction of neutrophil homotypic adhesion via sialophorin (CD43), a surface sialoglycoprotein restricted to haemopoietic cells. Immunology 1993; 80: 431–438
   PubMed Web of Science ®Google Scholar
• Majdic O., Stockl J., Pickl W. F., Bohuslav J., Strobl H., Scheinecker C., Stockinger H., Knapp W. Signaling and induction of enhanced cytoadhesiveness via the hematopoietic progenitor cell surface molecule CD34. Blood 1994; 83: 1226–1234
   PubMed Web of Science ®Google Scholar
• Goodfellow P. J., Darling S. M., Thomas N. S., Goodfellow P. N. A pseudoautosomal gene in man. Science 1986; 234: 740–743
   PubMed Web of Science ®Google Scholar
• Perlman E. J., Dickman P. S., Askin F. B., Grier H. E., Miser J. S., Link M. P. Ewing's sarcoma–routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study. Hum Pathol 1994; 25: 304–307
   PubMed Web of Science ®Google Scholar
• Goodfellow P. N. Expression of the 12E7 antigen is controlled independently by genes on the human x and Y chromosomes. Differentiation 1983; 23: S35–S39, Suppl
   PubMed Web of Science ®Google Scholar
• Latron F., Blanchard D., Cartron J. P. Immunochemical characterization of the human blood cell membrane glycoprotein recognized by the monoclonal antibody 12E7. Biochem J 1987; 247: 757–764
   PubMed Web of Science ®Google Scholar
• Dworzak M. N., Fritsch G., Buchinger P., Fleischer C., Printz D., Zellner A., Schollhammer A., Steiner G., Ambros P. F., Gadner H. Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood. Blood 1994; 83: 415–425
   PubMed Web of Science ®Google Scholar
• Stevenson A. J., Chatten J., Bertoni F., Miettinen M. CD99 (p30/32MIC2 neuroectodermal/Ewing's sarcoma antigen as an immunohistochemical marker. Appl Immunohistochem 1994; 2: 231–240
   Google Scholar
• Dworzak M N, Fritsch G, Buchinger P, Fleischer C, Printz D, Zellner A, Schollhammer A, Steiner G, Ambros P F, Gadner H. Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood. Blood Jan 15, 1994; 83(2)415–425
   PubMed Web of Science ®Google Scholar
• Choi E. Y., Park W. S., Jung K. C., Kim S. H., Kim Y. Y., Lee W. J., Park S. H. Engagement of CD99 induces upregulation of TCR and MHC class I and II molecules on the surface of human thymocytes. J Immunol 1998; 161: 749–754
   PubMed Web of Science ®Google Scholar
• Hahn J. H., Kim M. K., Choi E. Y., Kim S. H., Sohn H. W., Ham D. I., Chung D. H., Kim T. J., Lee W. J., Park C. K., Ree H. J., Park S. H. CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion. J Immunol 1997; 159: 2250–2258
   PubMed Web of Science ®Google Scholar
• Bernard G., Breittmayer J. P., De Matteis M., Trampont P., Hofman P., Senik A., Bernard A. Apoptosis of immature thymocytes mediated by E2/CD99. J Immunol 1997; 158: 2543–2550
   PubMed Web of Science ®Google Scholar
• Sohn H. W., Choi E. Y., Kim S. H., Lee I. S., Chung D. H., Sung U. A., Hwang D. H., Cho S. S., Jun B. H., Jang J. J., Chi J. G., Park S. H. Engagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells. Am J Pathol 1998; 153: 1937–1945
   PubMed Web of Science ®Google Scholar
• Waclavicek M., Majdic O., Stulnig T., Berger M., Sunder-Plassmann R., Zlabinger G. J., Baumruker T., Stockl J, Ebner C., Knapp W., Pickl W. F. CD99 engagement on human peripheral blood T cells results in TCR/CD3-dependent cellular activation and allows for Th1-restricted cytokine production. J Immunol 1998; 161: 4671–4678
   PubMed Web of Science ®Google Scholar
• Pinkus G. S., Thomas P., Said J. W. Leu-MI– a marker for Reed-sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues. Am J Pathol 1985; 119: 244–252
   PubMed Web of Science ®Google Scholar
• Chittal S. M., Caveriviere P., Schwarting R., Gerdes J., Al Saati T., Rigal-Huguet F., Stein H., Delsol G. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel. Am J Surg Pathol 1988; 12: 9–21
   PubMed Web of Science ®Google Scholar
• Agnarsson B. A., Kadin M. E. The immunophenotype of Reed-sternberg cells. A study of 50 cases of Hodgkin's disease using fixed frozen tissues. Cancer 1989; 63: 2083–2087
   PubMed Web of Science ®Google Scholar
• Gorgan T. M. Hogkin's disease. Surgical Pathology of the lymph nodes and related organs, vol 16, E.S. Jaffe. Saunders, Philadelphia, PA 1995; 133
   Google Scholar
• Grass H. J., Pinto A., Duyster J., Poppema S., Herrmann F. Hodgkin's disease: a tumor with disturbed immunological pathways. Immunol Today 1997; 18: 156–163
   PubMedGoogle Scholar
• Floettmann J. E., Ward K., Rickinson A. B., Rowe M. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology 1996; 223: 29–40
   PubMed Web of Science ®Google Scholar
• Knecht H., McQuain C., Martin J., Rothenberger S., Drexler H. G., Berger C., Bachmann E., Kittler E. L., Odermatt B. F., Quesenberry P. J. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology. Oncogene 1996; 13: 947–953
   PubMed Web of Science ®Google Scholar
• Cossman J., Annunziata C. M., Barash S., Staudt L., Dillon P., He W. W., Ricciardi-Castagnoli P., Rosen C. A., Carter K. C. Reed-Sternberg cell genome expression supports a B-cell lineage. Blood 1999; 94: 411–416
   PubMed Web of Science ®Google Scholar
• http://www.hodgkins.georgetown.edu/
   Google Scholar
• Mack T. M., Cozen W., Shibata D. K., Weiss L. M., Nathwani B. N., Hernandez A. M., Taylor C. R., Hamilton A. S., Deapen D. M., Rappaport E. B. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. New Eng J Med 1995; 332: 413–418
   PubMed Web of Science ®Google Scholar
• Gokhale D. A., Evans D. G., Crowther D., Woll P., Watson C. J., Dearden S. P., Fergusson W. D., Stevens R. F., Taylor G. M. Molecular genetic analysis of a family with a history of Hodgkin's disease and dyschondrosteosis. Leukemia 1995; 9: 826–833
   PubMed Web of Science ®Google Scholar
• Horwitz M., Wiernik P. H. Pseudoautosomal linkage of Hodgkin disease. Am J Hum Genet 1999; 65: 1413–1422
   PubMed Web of Science ®Google Scholar
• Kieff E. Epstein-Barr virus and its replication. Field of virology. 3^rd ed. Vol 2, BN Fields, DM Knipe, PM Howley. Lippincott-Raven, Philadelphia 1996; 2343
   Google Scholar
• Kaye K. M., Izumi K. M., Mosialos G., Kieff E. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues. J Virol 1995; 69: 675–683
   PubMed Web of Science ®Google Scholar
• Pokrovskaja K., Trivedi P., Klein G., Szekely L. Epstein-Barr virus-encoded LMP-1 protein upregulates the pNDCF group of nucleoskeleton-cytoskeleton-associated proteins. J Gen Virol 1997; 78: 2031–2040
   PubMed Web of Science ®Google Scholar
• Brodeur S. R., Cheng G., Baltimore D., Thorley-Lawson D. A. Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs. J Biol Chem 1997; 272: 19777–19784
   PubMed Web of Science ®Google Scholar
• Miller W. E., Mosialos G., Kieff E., Raab-Traub N. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation. J Virol 1997; 71: 586–594
   PubMed Web of Science ®Google Scholar
• Izumi K. M., Kieff E. D. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB. Proc Natl Acad Sci USA 1997; 94: 12592–12597
   PubMed Web of Science ®Google Scholar
• Devergne O., Hatzivassiliou E., Izumi K. M., Kaye K. M., Kleijnen M. F., Kieff E., Mosialos G. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Mol Cell Biol 1996; 16: 7098–7108
   PubMed Web of Science ®Google Scholar
• Sandberg M., Hammerschmidt W., Sugden B. Characterization of LMP-1′s association with TRAF1, TRAF2, and TRAF3. J Virol 1997; 71: 4649–4656
   PubMed Web of Science ®Google Scholar
• Kieser A., Kilger E., Gires O., Ueffing M., Kolch W., Hammerschmidt W. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J 1997; 16: 6478–6485
   PubMed Web of Science ®Google Scholar
• Eliopoulos A. G., Young L. S. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1(LMP1). Oncogene 1998; 16: 1731–1742
   PubMed Web of Science ®Google Scholar
• Gires O., Kohlhuber F., Kilger E., Baumann M., Kieser A., Kaiser C., Zeidler R., Scheffer B., Ueffing M., Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J 1999; 18: 3064–3073
   PubMed Web of Science ®Google Scholar
• Deacon E. M., Pallesen G., Niedobitek G., Crocker J., Brooks L., Rickinson A. B., Young L. S. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 1993; 177: 339–349
   PubMed Web of Science ®Google Scholar
• Herbst H., Dallenbach F., Hummel M., Niedobitek G., Pileri S., Muller-Lantzsch N., Stein H. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci U S A 1991; 88: 4766–4770
   PubMed Web of Science ®Google Scholar
• Pallesen G., Hamilton-Dutoit S. J., Rowe M., Young L. S. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991; 337: 320–322
   PubMed Web of Science ®Google Scholar
• Wood K. M., Roff M., Hay R. T. Defective IkBα in Hodgkin cell lines with constitutively active NF-kB. Oncogene 1998; 16: 2131–2139
   PubMed Web of Science ®Google Scholar
• Krappmann D., Emmerich F., Kordes U., Scharschmidt E., Dörken B., Scheidereit C. Molecular mechanisms of constitutive NF-kB/Rel activation in Hogdkin/Reed-Sternberg cells. Oncogene 1999; 18: 943–953
   PubMed Web of Science ®Google Scholar
• Gires O., Zimber-Strobl U., Gonnella R., Ueffing M., Marschall G., Zeidler R., Pich D., Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J 1997; 16: 6131–6140
   PubMed Web of Science ®Google Scholar
• Lee I. S., Kim M. K., Choi E. Y., Mehl A., Jung K. C., Gil M. C., Rowe M., Park S. H. CD99 expression is positively regulated by Spl, and is negatively regulated by Epstein-Barr virus Latent Membrane Protein1 (EBV LMP1) via NF-kappaB, In press
   Google Scholar
• Knecht H., Berger C., McQuain C., Rothenberger S., Bachmann E., Martin J., Esslinger C., Drexler H. G., Cai Y. C., Quesenberry P. J., Odermatt B. F. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease. Oncogene 1999; 18: 7161–7167
   PubMed Web of Science ®Google Scholar